Neuron23 snags US$100 million for AI drug discovery

Apr 4, 2022

Related news

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Dec 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI drug discovery platform raises Series B funding

Aug 11
,
0221
AI
Cleantech
Healthcare
Investment
Life Science
Press

Major venture capital investment in European life sciences will fuel occupier market

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capitalists raise more than $100bn to target life sciences

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Oct 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI’s Smarts Now Come With a Big Price Tag

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Dec 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analyst reports trend in LS research funding

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding